Page last updated: 2024-10-31

methoxyflurane and Bright Disease

methoxyflurane has been researched along with Bright Disease in 1 studies

Methoxyflurane: An inhalation anesthetic. Currently, methoxyflurane is rarely used for surgical, obstetric, or dental anesthesia. If so employed, it should be administered with NITROUS OXIDE to achieve a relatively light level of anesthesia, and a neuromuscular blocking agent given concurrently to obtain the desired degree of muscular relaxation. (From AMA Drug Evaluations Annual, 1994, p180)
methoxyflurane : An ether in which the two groups attached to the central oxygen atom are methyl and 2,2-dichloro-1,1-difluoroethyl.

Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gauert, WB1
Buschman, D1
Parmley, RT1
Schloerb, PR1

Other Studies

1 other study available for methoxyflurane and Bright Disease

ArticleYear
Renal function associated with methoxyflurane anesthesia.
    Southern medical journal, 1969, Volume: 62, Issue:12

    Topics: Adult; Aged; Female; Glomerulonephritis; Humans; Hydronephrosis; Intubation, Intratracheal; Kidney;

1969